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†School of Biomedical Engineering and Sciences (SBES), Virginia Tech-Wake Forest University, Blacksburg, VirginiaABSTRACT Irreversible electroporation (IRE) is emerging as a powerful tool for tumor ablation that utilizes pulsed electric
fields to destabilize the plasma membrane of cancer cells past the point of recovery. The ablated region is dictated primarily
by the electric field distribution in the tissue, which forms the basis of current treatment planning algorithms. To generate
data for refinement of these algorithms, there is a need to develop a physiologically accurate and reproducible platform on which
to study IRE in vitro. Here, IRE was performed on a 3D in vitro tumor model consisting of cancer cells cultured within dense
collagen I hydrogels, which have been shown to acquire phenotypes and respond to therapeutic stimuli in a manner analogous
to that observed in in vivo pathological systems. Electrical and thermal fluctuations were monitored during treatment, and this
information was incorporated into a numerical model for predicting the electric field distribution in the tumors. When correlated
with Live/Dead staining of the tumors, an electric field threshold for cell death (500 V/cm) comparable to values reported in vivo
was generated. In addition, submillimeter resolution was observed at the boundary between the treated and untreated regions,
which is characteristic of in vivo IRE. Overall, these results illustrate the advantages of using 3D cancer cell culture models to
improve IRE-treatment planning and facilitate widespread clinical use of the technology.INTRODUCTIONIrreversible electroporation (IRE) is a nonthermal, focal
ablation technique that has shown tremendous promise as
an effective cancer therapy (1–7). This procedure uses elec-
trodes to apply a series of short-duration, high-intensity
electric pulses through tissue. At the appropriate parame-
ters, the pulses produce irreversible structural changes in
the cell membranes within the targeted region, generating
a predictable range of cell death with submillimeter resolu-
tion (8,9). IRE-based therapy is in the beginning phases of
human clinical trials for prostate, kidney, liver, lung, and
pancreatic cancer (4–7,10). Because the mechanism of
cell death is linked to altered membrane permeability and
not thermal processes, IRE spares important extracellular
matrix components, such as major blood vessel and nerve
architecture (11,12). This enables the treatment of tumors
that are normally considered surgically inoperable, due to
their close proximity to these sensitive structures (2,3). In
addition, IRE is not subject to heat-sink effects from nearby
blood flow, and IRE-induced lesions heal rapidly within
2 weeks after treatment (13). The lesion that develops
during IRE is visible in real time on multiple imaging plat-
forms (13–16), which is of great benefit to the surgeon, as
there can be direct visual confirmation of treatment.
Developing accurate IRE-treatment planning models is
essential for the technology to achieve widespread clinical
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0006-3495/12/11/2033/10 $2.00upon one’s ability to predict the electric field distribution
in the tissue and an a priori knowledge of the electric field
threshold for cell death given a specific set of pulse param-
eters (duration, number, repetition rate). This is a com-
plicated task. Altered membrane permeability leads to
nonlinear changes in the dielectric tissue properties. In
addition, although thermal damage is avoided by properly
tuning the pulse parameters, there can still be significant
Joule heating within the tissue that influences the dielectric
response. Many studies have been performed to investigate
the physiological response of various tissue types to IRE
pulses without focusing on the engineering aspects of treat-
ment planning (17–20). To the best of our knowledge, the
electric field threshold for cell death has only been well
documented in vivo for liver tissue (9,21,22), brain tissue
(23), and an orthotopic model of mammary tumors in
mice (24). Also, studies conducted to elucidate the dynamic
relationship between IRE and changes in dielectric proper-
ties are limited to experiments on liver (25,26), skin (27),
brain (28), kidney (29), and a subcutaneous model of fibro-
sarcoma in mice (30). Many types of tissue remain unex-
plored, including a variety of tumors. This can partially be
attributed to the cost and difficulty associated with perform-
ing in vivo experiments.
A broader literature exists on in vitro cell suspensions
(31–33). In this platform, the electric field threshold for
cell death can be readily determined using commercially
available indicators of membrane integrity or mitochondrial
activity. However, there are significant limitations associ-
ated with using information derived from this model for
treatment planning. Cells in suspension do not provide an
accurate representation of their in vivo morphology, andhttp://dx.doi.org/10.1016/j.bpj.2012.09.017
2034 Arena et al.the cellular response obtained from these cultures is altered
in the absence of cell-cell and cell-matrix interactions. In
addition, cells in suspension lack the structural foundation
necessary to provide useful spatial information after pulse
delivery. To account for spatial information, researchers
have proposed using vegetable tissue, such as potato. Pota-
toes are useful for economically determining field thresh-
olds, because regions subject to IRE are markedly darker
(34,35). Also, changes in potato dielectric properties during
IRE have been shown to mimic those seen in vivo (34).
However, although vegetables are useful for economically
investigating trends, it is difficult to draw direct compari-
sons to tissue with the absence of physiologically responsive
cancer cells.
There is a clear need for a system that can be used to
model IRE-based cancer therapies and improve treatment
planning in a more physiologically relevant manner without
requiring the use of animal models. It has been well estab-
lished in the fields of tissue engineering and cancer biology
that cells cultured within a three-dimensional (3D) in vitro
environment are capable of acquiring phenotypes and re-
sponding to stimuli in a manner analogous to that observed
in in vivo biological systems (36–38). We hypothesize that
engineering a platform for 3D tumor growth that mimics
an in vivo tumor microenvironment will allow the cells to
respond to IRE-based therapies in a manner that can be
directly related to an in vivo response and therefore have
direct clinical impact. Several groups have investigated
the phenotypic response of culturing cancer cells in a 3D
in vitro environment (39–41). Specifically, our group has
developed 3D bioengineered tumors that exhibit phenotypic
characteristics representative of in vivo cancer progression
(40). This model involves culturing cancer cells within
dense collagen I hydrogels, which facilitates proper cell-
cell and cell-matrix interactions and encourages the devel-
opment of a necrotic core, intracellular levels of hypoxia,
and angiogenic potential. Therefore, these collagen I
hydrogel-based bioengineered tumors can potentially be
used for more accurate modeling of IRE-based cancer
therapies in an in vitro setting.
In this study, a 3D cancer cell culture model is introduced
for improving IRE-treatment planning. Changes in electri-
cal conductivity and temperature were measured for a range
of applied voltages. In addition, the role of cell concentra-
tion was explored in producing an electrically relevant
model of tissue. After treatment, a Live/Dead assay was per-
formed on intact constructs to demonstrate the relationship
between the applied voltage and the extent of cell death.
Select samples were fixed and processed for hematoxylin
and eosin (H&E) staining. All data generated were incorpo-
rated into a numerical model. This allowed for the accurate
determination of the electric field threshold for cell death
(500 V/cm). These results were then compared to experi-
ments using in vitro cell suspensions, which predicted a
much higher threshold for cell death (1500 V/cm), illus-Biophysical Journal 103(9) 2033–2042trating the benefits of 3D cell culture models for IRE-treat-
ment planning.MATERIALS AND METHODS
Cell culture
Primary dispersed murine pancreatic cancer cells (provided by Dr. Dieter
Saur, Technische Universita¨t Mu¨nchen, Munich, Germany) were estab-
lished from pancreatic ductal adenocarcinomas (PDACs) of Ptf1aCre/þ;
LSL-KrasG12D/þ mice on a C57Bl/6J genetic background. Specifically,
primary pancreatic tumors (PPTs) were removed from a mouse (number
8182) and digested in 10 ml Dulbecco’s modified Eagle’s medium
(DMEM) containing 150 U/ml collagenase Type 2 (Worthington, Lake-
wood, NJ) as described (42). Single PPT-8182 cell suspensions were culti-
vated in DMEM (supplemented with L-glutamine, ATCC, Manassas, VA)
containing 10% fetal bovine serum (Sigma Aldrich, St. Louis, MO) and
1% penicillin/streptomycin (Invitrogen, Carlsbad, CA). These cells have
been shown to replicate human pancreatic cancer in terms of histology,
metastasis, and genetic alterations (42–44).Collagen I hydrogel in vitro tumors
Collagen I hydrogel-based in vitro tumors were fabricated as described
previously (40). Briefly, Sprague Dawley rat tail tendons were dissolved
in 10 mM HCL under agitation overnight, the suspension was centrifuged
at 22,500  g for 45 min, and the supernatant containing the collagen I
was decanted. The concentration of the collagen I solution was calculated
using dry-weight measurements, and the solution was sterilized by layering
chloroform beneath the collagen I for 24 h. A neutralizing buffer containing
10 DMEM (Mediatech, Manassas, VA), 1N NaOH, and dH20 was used to
resuspend a pellet of PPT-8182 cells to obtain a final seeding density of 5
106 or 50  106 cells/ml. The cell suspension was then gently mixed on
ice with an appropriate volume of collagen I to achieve a concentration
of 8 mg/ml, which provides a matrix stiffness close to measured values
for in vivo tumors (45), and pipetted into 10-mm-diameter cylindrical
molds. After a 20-min polymerization period at 37C, the cancer-cell-
seeded hydrogels were removed from the molds and cultured in complete
media overnight before IRE pulse delivery. It is important to note that the
5  106 cells/ml seeding density was used in a majority of the experiments,
because this was found to adequately maintain cell viability throughout the
construct over a 24-h period. The seeding density of 50  106 cells/ml was
used to investigate whether a higher concentration of cells could modulate
the electrical properties of the in vitro tumors. Control hydrogels were also
fabricated using the neutralizing buffer alone without cells as a comparison
to elucidate any effects due to electroporation.IRE pulse delivery for in vitro tumors
In vitro tumors were temporarily removed from media and placed in
six-well plates for IRE pulse delivery. Pulses were applied through custom
electrodes (1.3 mm Ø) fabricated from stainless steel hollow dispensing
needles (Howard Electronic Instruments, El Dorado, KS) using the ECM
830 electroporation system (BTX-Harvard Apparatus, Holliston, MA)
(Fig. 1 a). The pulse duration (100 ms), number (80 pulses), and repetition
rate (1 pulse/s) were held constant and chosen based on established proto-
cols (8,46). In the 5  106 cells/ml seeded in vitro tumors, the applied
voltage was varied (0 V, 150 V, 300 V, 450 V, and 600 V) to generate
voltage/distance ratios of 0–1800 V/cm across the 3.35-mm electrode
spacing (center to center). In the no-cells control and 50  106 cells/ml
seeded in vitro tumors, the applied voltage was held constant at 300 V.
Before the full IRE protocol, a prepulse was delivered at 30 V to determine
the baseline electrical conductivity of the in vitro tumors. A port located
2.3 mm below the center point between the electrodes was included in
FIGURE 1 (a) Experimental setup for IRE pulse delivery in collagen I
hydrogel-based in vitro tumors in which PDAC cells are embedded. (b)
Geometry and mesh used in the finite element model for simulating the
electrical and thermal response of the in vitro tumors to IRE.
IRE on 3D In Vitro Tumors 2035the electrode design to monitor temperature in real time during treatment
with a fiber optic probe (Luxtron m3300, LumaSense Technologies, Santa
Clara, CA). In addition, current (TCP305 and TCPA300, Tektronix, Beaver-
ton, OR) and voltage (P5200, Tektronix) were recorded noninvasively
during treatment. The generated temperature, current, and voltage data
were used to validate the numerical model for predicting the electric field
threshold for IRE (see Results, Numerical model validation). Further, to
eliminate the influence of the temperature probe on the electrical measure-
ments, samples used for monitoring temperature were separate from those
used for performing the viability analysis. After each treatment, the tumor
diameter and thickness were measured with calipers for use in determining
electrical properties. Each parameter combination was tested a minimum of
three times (n ¼ 3).Viability analysis for in vitro tumors
After IRE pulse delivery, the in vitro tumors were incubated in complete
media for 2 h before conducting a Live/Dead assay to allow any cells expe-
riencing reversible electroporation to fully recover. Calcein acetomethoxy
(AM) (4 mM; lem ¼ 515 nm; Invitrogen) was added to the media 30 min
before analysis, and propidium iodide (1.5 mM; lem ¼ 617 nm; Invitrogen)
was added to the media 5 min before analysis. Calcein AM stains live cells,
as it can be transported across the cell membrane and fluoresces when intra-
cellular esterases remove the attached AM group. Propidium iodide (PI) flu-
orescently labels dead cells, as it only enters compromised cell membranes
and binds to nucleic acids. A Leica DMI 6000 fluorescent microscope (Leica
Microsystems, Buffalo Grove, IL) was used to tile a set of images and recon-
struct the entire surface of the IRE-treated in vitro tumors. A Zeiss LSM 510
laser scanning confocal microscope (Carl Zeiss, Thornwood, NY) was used
to analyze the live-dead cell interface and reconstruct a Z-stack. Viability
imaging was performed on complete, nonsectioned in vitro tumors.
In addition, cytoskeletal disruption within the IRE-treated regions
was investigated. The tumors were stained with rhodamine phalloidin
(Invitrogen), a high-affinity probe for F-actin, and NucBlue fixed cell stain
(Invitrogen) to visualize nuclei. The samples were then routinely fixed in
10% formalin, paraffin-embedded, and sectioned at 5 mm for histological
analysis. An H&E stain was performed to further analyze cell death within
the IRE-treated regions.TABLE 1 Physical properties used in numerical simulations
Parameter Tumor Electrodey PlatezAnalysis of IRE on cell suspensions
The details of the methods associated with IRE pulse delivery and viability
analysis for cell suspensions can be found in the Supporting Material.k (W m1 K1) 0.6 14 0.14
c (J kg1 K1) 4181.8 477 1300
r (kg m3) 997.8 7900 1050
s0 (S m
1) 1.2 2.22  106 1  1016
yElectrode numerical data are taken from Al Sakere et al. (46).
zPlate numerical data are taken from Chiu and Fair (67).Numerical modeling
Description of the model geometry and mesh
Finite element analysis software (COMSOL Multiphysics 4.2a, Stock-
holm, Sweden) was used to solve for the electric field and temperaturedistributions within the in vitro tumor during IRE therapy. A 3D geome-
try was constructed with dimensions equivalent to those in the experi-
mental setup (Fig. 1 b). Each treatment was performed in a single well
of a polystyrene six-well plate with a thickness of 1.2 mm and radius of
1.9 cm. The stainless steel electrodes had a length of 5.5 cm through
which heat could dissipate. A finer mesh was used that consisted of
67,557 tetrahedral elements. This resulted in a <0.02% difference in
temperature calculations at the site of the fiber optic probe upon succes-
sive refinements.
Determination of baseline electrical properties
To solve for the baseline electrical conductivity of the in vitro tumors, a
three-variable parametric study was performed on the tumor radius (4.5,
4.75, and 5 mm), thickness (2, 2.5, and 3 mm), and conductivity (0.25,
0.5, 0.75, 1.0, 1.25 S/m) using the numerical model. Based on the
pulse characteristics associated with IRE and the subdomain dielectric
(Table 1) and geometry properties, propagation effects and transients
were assumed to be negligible, and the quasistatic approximation was
implemented (47,48). This allows for definition of the electric field magni-
tude as E ¼ Vf, where f is the electric potential. Therefore, the spatial
distribution of electric potential can be expressed as
0 ¼ V , ðs0EÞ; (1)
where s0 is the baseline electrical conductivity. Equation 1 was used to
solve for the total current flowing in the in vitro tumor when a constant30 V prepulse was applied to the energized electrode, with the other elec-
trode set as ground. Specifically, the magnitude of the current density (J)
was integrated over a cut plane dividing the geometry in half between the
electrodes. All outer boundaries, excluding the electrodes, were assumed
to be electrically insulating (n ∙ J¼ 0), and the initial voltage (V0) within
each subdomain was 0 V.
The resulting data relating current (I) to each parameter combination
were imported into Mathematica 8.0 (Wolfram, Champaign, IL). A regres-
sion analysis was performed to determine the baseline electrical conduc-
tivity using the measured current from the prepulse routine along with
the corresponding tumor dimensions.
For comparison to the experimentally determined values for in vitro
tumor baseline electrical conductivity, a theoretical calculation was
performed using effective medium theory (EMT) (49). Specifically, Max-
well’s equation for a dilute suspension was solved for the effective conduc-
tivity, s:
se  s
2se þ s ¼ f
se  sp
2se þ sp; (2)
where se is the extracellular medium conductivity (1.2 S/m), sp is the
homogeneous particle conductivity (0.2  104 S/m for an equivalent
cell (49)), and f is the volume fraction of particles dispersed in the medium.
Equation 2 is valid for predicting the low-frequency effective conductivity
of a cell suspension for volume fractions up to 0.8 (50). This allowed for
extrapolations of tumor baseline conductivity at cell concentrations higher
than those tested experimentally to estimate what cell concentration would
be required to be electrically similar to tissue.Biophysical Journal 103(9) 2033–2042
2036 Arena et al.Determination of transient current and temperature
development
The temperature distribution (T) within the in vitro tumor was obtained by
transiently solving a modified heat conduction equation with inclusion of
the Joule heating-source term (J , E ¼ sjEj2):
rc
vT
vt
¼ V , ðkVTÞ þ t

sjEj2
P
; (3)
where t is the pulse duration, P is the period of the pulses, k is the thermal
conductivity, c is the specific heat at constant pressure, and r is the density(Table 1). Due to the fact that the collagen-I-hydrogel-based tumors
have a water content of >98%, the thermal properties of the tumor were
chosen to be the same as those of water. The tumor baseline electrical
conductivity (1.2 S/m) was determined experimentally from the average
of the no-cells and 5  106-cells/ml trials (Table 2), as there was no statis-
tical difference between those two groups (see Results, Determination of
baseline electrical properties). In addition, the tumor radius (4.705 mm)
and thickness (2.45 mm) were also selected by averaging the measurements
from the same groups. Equation 1 was modified to include a temperature
dependence on electrical conductivity:
0 ¼ V , ðsðTÞEÞ; (4)
where
sðTÞ ¼ s0ð1þ aðT  T0ÞÞ (5)
and a is the coefficient that describes how the conductivity varies with
temperature. This parameter was estimated to be 2%/C by optimizing
the measured change in temperature and current throughout treatment to
match the theoretical changes. The optimization was performed by running
a parametric study on a at 0.5%/K increments. A value of 2%/C is similar
to values observed in biological tissue (51).
At each time step, the conductivity and electric field are determined and
updated in the Joule heating term. As opposed to simulating individual
pulses, a duty cycle approach was employed to calculate the temperature
increase resulting from various IRE protocols. A constant voltage (150,
300, 450, and 600 V) was applied to the energized electrode, with the other
electrode set as ground. The Joule heating term was scaled by the duty cycle
(t/P ¼ 100  106) to ensure that equal amounts of energy were deposited
into the tissue by the onset of each pulse. This approach has been validated
in our previous work (29,52) as providing an accurate prediction of the
temperature distribution with a fraction of the computational requirements
necessary to resolve microsecond-order pulses within a treatment lasting
several seconds.
All outer boundaries, excluding the outer vertical edge of the well
plate, were treated as convective cooling (n ∙ (kVT) ¼ h(Text  T))
with an exterior temperature of 22C and a heat-transfer coefficient
of 25 (W m2 K1). The vertical edge of the well plate was treated as
thermally insulating (n ∙ (kVT) ¼ 0), and the initial temperature (T0)
within each subdomain was the same as the exterior temperature. Interme-
diate time stepping was used to ensure that at least one time step was taken
each second.TABLE 2 Baseline electrical conductivity from prepulse
measurements and EMT theory
Concentration
(cells ml1) Experimental s0 (S m
1) Theoretical s0 (S m
1)
0 (n ¼ 6) 1.185 0.09 1.2
5  106 (n ¼ 15) 1.245 0.11 1.2
50  106 (n ¼ 6) 1.085 0.08 1.1
Biophysical Journal 103(9) 2033–2042Determination of electric field threshold for cell death
After the in vitro tumor viability analysis, the area, height, and width of the
treated region were measured using Image J (National Institutes of Health,
Bethesda MD) for three samples of each parameter combination and aver-
aged. All measurements were made on the surface of the tumors. The width
measurements were taken in the x-direction and the height measurements
were taken in the y-direction. The electric-field threshold for cell death
was determined in three ways, using the area, height, and width measure-
ments (Table 3). For determining the threshold from the area measurement,
the electric field on the top surface of the tumors was integrated at the end
of the treatment (t ¼ 80 s) for values greater than the threshold value. The
threshold value was varied until the area calculation best matched the
measured values within 1 V/cm (excluding the area of the electrodes).
For determining the threshold from the height and width measurements,
the value of the electric field at a point on the surface corresponding to
the measurements was taken at the end of treatment.RESULTS
Physiological response to IRE pulse delivery
within in vitro tumors
When the 30 V prepulse was delivered to determine the
baseline electrical conductivity of the in vitro tumors, no
cell death was observed as a result of the treatment (Fig. 2
a). At this low voltage/distance ratio (90 V/cm taken from
the center-to-center electrode spacing), any electroporation
that may have occurred was reversible (21). Minimal cell
death was observed where the electrodes punctured the
surface of the tumors. When the electric field strength was
increased to 150 V, cell death was observed on the medial
side of both electrodes, but the treated regions did not
expand far enough to completely connect (Fig. 2 b). Rather,
a transition zone of both live and dead cells was observed at
the center of the two electrodes. At the higher electric-field
strengths (300 V and 450 V), the treated region was ampli-
fied with increasing electric-field strength, expanding in
both the x- and y-directions (Fig. 2, c and d). The nonspecific
regions of cell death present around the periphery of the
tumors were a result of handling the samples with tweezers.
A sharp interface between live and dead cells was
observed at the threshold boundary for cell death with
submillimeter resolution (Fig. 3 a). The specificity of these
treatments was similar to what has been achieved during
in vivo IRE pulse delivery (8,9). Confocal microscopy
was used to show that the IRE-induced cell death was
uniform in the z-direction (Fig. 3 b), demonstrating that
the in vitro tumors can provide spatial information in both
the xy and z planes. In addition, the 3D reconstruction high-
lighted the transition zone at the live/dead cell interface
where there were clear contrasting gradients of live and
dead cells that converged at the threshold boundary for
cell death.
Histology was used to further assess the IRE-induced
cell death in the in vitro tumors. Again, a sharp interface
between live and dead cells was evident from an H&E stain
(Fig. 4 a). The PPT-8182 cells within the untreated regions
TABLE 3 Treatment dimensions and electric field threshold for cell death
Voltage (V) Conc. (cells ml1) Area (mm2) Height (mm) Width (mm) ET (Area, Height, and Width) (V cm
1)
300 (n ¼ 3) 5  106 16.285 2.73 4.025 0.40 4.915 0.34 491, 501, 500
450 (n ¼ 3) 5  106 25.805 1.48 5.835 0.40 5.585 0.13 498, 502, 470
Conc., concentration.
IRE on 3D In Vitro Tumors 2037appeared normal with healthy nuclei and complete cyto-
plasms, signifying that they were not affected by the IRE
pulse delivery (Fig. 4 c). Conversely, the cells within the
IRE-treated regions were completely destroyed except for
their remaining nuclei, which appeared abnormal and no
longer contained nucleoli (Fig. 4 b). The absence of cyto-
plasmic material indicated that the IRE pulses had irrevers-
ibly compromised the cell membranes, leaving clear voids
in the collagen hydrogel where the cells had been.
An F-actin stain was performed to determine the effect of
the IRE pulses on the actin cytoskeleton of PPT-8182 cells
cultured within the in vitro tumors (Fig. 4, d and e). PPT-
8182 cells within the untreated regions had spherical
morphologies with high concentrations of actin present
around the periphery of the cells (Fig. 4 e). Since the tumors
were only cultured overnight before IRE pulse delivery,
the cells did not proliferate into large clusters or develop
invasive processes, as observed previously (40). The cyto-
skeleton of cells within the IRE-treated regions seems to
be permanently disrupted, appearing speckled and faded
(Fig. 4 d). This suggests that the IRE pulses led to degrada-FIGURE 2 A live/dead assay for assessment of cell death after IRE pulse
delivery of 30 V (a), 150 V (b), 300 V (c), and 450 V (d). Live cells were
stained green using Calcein AM and dead cells were stained red using
propidium iodide. Images were tiled to reconstruct the entire surface of
the IRE-treated in vitro tumors. The bright rings encircling the hydrogels
are a consequence of out-of-plane fluorescence at the rounded edges. Scale
bars, 2.5 mm.tion of the actin filaments, which differs from reversible
electroporation, where actin filaments have been shown to
reassemble 1 h after electroporation (53). The presence of
a disrupted cytoskeleton within the IRE-treated cells re-
vealed that some cytoplasmic material was still present after
IRE pulse delivery. Over time, this remaining cytoplasm
was either fully degraded or washed away during histology
preparation (Fig. 4 b). In treatment groups where the Live/
Dead stain was not performed until 24 h after IRE treatment,
there were no visible PI-stained dead cells within the treated
regions, indicating that the nuclei had also been fully
degraded or washed away (data not shown).Determination of baseline electrical properties
The baseline electrical conductivity of the in vitro tumors is
given in Table 2. A one-way ANOVAwas used to investigate
the effect of cell concentration on the rank of baseline
conductivity. In the event of a significant main effect, pair-
wise comparisons were completed using Tukey’s honestly
significant difference (HSD). All statistical analysis were
conducted using JMP 9 (SAS Institute, Cary, NC) with a
significance level of p % 0.05. Results indicate that a cell
concentration of 50  106 cells/ml is high enough to pro-
duce a detectable decrease of ~0.1 S/m in baseline conduc-
tivity when compared to the 5 106 cells/ml group. Further,
there is no significant difference in baseline conductivity
between the no-cells and 5  106 cells/ml groups. TheseFIGURE 3 (a) A sharp interface between live (green; left) and dead (red;
right) cells at the threshold boundary for cell death with submillimeter
resolution. (b) 3D reconstruction at this interface highlights the transition
zone between live and dead cells and demonstrates that IRE-induced cell
death was uniform throughout the in vitro tumors. The dotted lines in (a)
define the representative region from which the image in (b) was taken.
Scale bars, 400 mm (a) and 200 mm (b).
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FIGURE 4 (a) An H&E stain for further assess-
ment of cell viability after IRE pulse delivery of
450 V through in vitro tumors seeded with 50 
106 cells/ml. (b and c) Cells located within the
IRE-treated regions appeared to be devoid of most
cytoplasmic material (b), whereas cells located
within the untreated regions appeared normal,
with intact cell membranes (c). (d and e) Dotted
lines in (a) define the transition zone at the live/
dead cell interface. An F-actin stain (red) was
used to determine the effect of IRE-pulse delivery
on the cytoskeleton of PPT-8182 cells cultured
within the IRE-treated (d) and untreated (e) regions
of the in vitro tumors. The actin cytoskeleton within
the IRE-treated cells appears permanently disrup-
ted. Nuclei were stained with DAPI (blue). Scale
bars, 250 mm (a), 50 mm (b and c), and 25 mm
(d and e).
2038 Arena et al.results agree well with the theoretical calculations based
on EMT. Specifically, a cell concentration on the order of
48  106 cells/ml is required to reduce the baseline conduc-
tivity by 0.1 S/m. This corresponds to a volume fraction of
cells of ~0.06.Numerical model validation
The numerical model was validated through comparisons to
experimentally measured changes in current and tempera-
ture between the first and last pulse of treatment (Fig. 5).
The predicted change in current delivered through the
in vitro tumors was accurate around 1 standard deviation
at all voltages tested (Fig. 5 a). As the applied voltage
increased, the change in current during treatment also
increased. This change is nonlinear due to the inclusion
of a temperature-dependent conductivity. The predicted
change in temperature at the location of the fiber optic
temperature probe was accurate within a single standard
deviation at all voltages tested (Fig. 5 b). The temperature
change during treatment also increased nonlinearly with
the applied voltage. The inclusion of the actual metal elec-
trodes and polystyrene plate was required to dissipate the
heat and match experimental temperatures using a reason-
able heat-transfer coefficient for free convection with air
of 25 W m2 K1 (54).FIGURE 5 Change in current (a) and temperature (b) delivered through
the in vitro tumors during IRE performed at 150 V, 300 V, 450 V, and 600 V.
The treatment consisted of 80 100-ms-long pulses delivered at a rate of 1/s.
The bars with 1 standard deviation indicate the experimentally measured
values. The data points along the line illustrate the results of the numerical
model, which was optimized to match the measured changes in current and
temperature from onset to offset of pulsing.Determination of transient current and
temperature development
Representative surface plots of the predicted electric field,
temperature, and electrical conductivity distributions for
an applied voltage of 300 V are shown in Fig. 6. The
maximum temperature at the end of treatment occurred at
the center of the domain. For all simulated voltages, the
maximum temperature was calculated to be 23C, 27C,
35C, and 51C for applied voltages of 150 V, 300 V, 450
V, and 600 V, respectively, with the baseline set at 22C.
Experimentally, an applied voltage of 600 V resulted inBiophysical Journal 103(9) 2033–2042the formation of a void at the center of the in vitro tumors,
presumably due to collagen denaturation (data not shown)
(55). By comparing the dimensions of the void with the
temperature distribution, it was conservatively estimated
that temperatures >45C should be avoided in future exper-
iments on this in vitro platform.
Due to the inclusion of a temperature-dependent electri-
cal conductivity, the maximum conductivity at the end
of treatment also occurred at the center of the domain.
For all simulated voltages, the maximum conductivity was
calculated to be 1.2 S/m, 1.3 S/m, 1.5 S/m, and 1.9 S/m
for applied voltages of 150 V, 300 V, 450 V, and 600 V,
respectively, with the baseline set at 1.2 S/m. Even at the
highest voltages, the noticeable increase in conductivity
had an insignificant effect on the electric-field distribution
in the current experimental setup. For example, between
FIGURE 6 Surface plots from the numerical
model showing the electric-field distribution (a),
temperature distribution (b), and conductivity
distribution (c) at the end of an 80-s IRE treatment
at 300 V. The upper and lower triangles along the
scale bars indicate maximum and minimum values,
respectively, present within the entire domain. In
the case of (c) these values are consistent with
those reported in Table 1 for the electrode and plate
domains. Regions experiencing values outside the
given color range (e.g., electrode and plate conduc-
tivity) assume the color associated with the limits
of the displayed data.
IRE on 3D In Vitro Tumors 2039the onset and offset of pulsing, the area of the top surface of
the in vitro tumors exposed to an electric field >500 V/cm
changed by 0.01 mm2, 0.02 mm2, 0.09 mm2, and 0.4 mm2
for applied voltages of 150 V, 300 V, 450 V, and 600 V,
respectively. This correlates with a slight change in the
dimensions of the 500 V/cm electric-field contour from
the onset to offset of pulsing. However, even at 600 V, the
height of the area encompassed by the contour (y-direction)
changed by only 0.08 mm, and the width (x-direction)
changed by only 0.04 mm. All of these variations are within
1 standard deviation of experimentally measured values
(Table 3).Determination of electric-field threshold for cell
death of in vitro tumors
Only applied voltages of 300 V and 450 V were used to
determine the electric-field threshold for cell death (Table
3). As mentioned, an applied voltage of 150 V did not
produce a complete lesion extending past the lateral surfaces
of the electrodes or completely connecting in the center
(Fig. 2), which eliminated the possibility of accurate width
measurements. At 600 V, void formation at the center of
the in vitro tumors, presumably due to collagen denatur-
ation, also eliminated the possibility of accurate measure-FIGURE 7 Overlay of electric-field contours predicted by the numerical
model at the end of 80-s IRE treatments at 300 V (a) and 450 V (b) with the
corresponding live/dead tiled images from Fig. 2. The field contours shown
are at 400 V/cm (inner), 500 V/cm (middle), and 600 V/cm (outer). The
contour labeled 500 V/cm denotes the threshold for cell death. Scale
bars, 2.5 mm.ments. There was a close agreement in the electric-field
threshold for cell death as determined by both the 300 V
and 450 V treatment groups. In the 300 V group, averaging
the electric-field threshold as determined by each separate
measurement resulted in a threshold of 497 V/cm. In a simi-
lar way, in the 450 V group, the average threshold from
each measurement was 490 V/cm. Between the groups,
the highest variability was present within thresholds deter-
mined from width measurements. This is likely due to the
difficulty in measuring lesion width near the electrodes
and the steep gradient in electric potential near the lateral
electrode surfaces. When width measurements were omitted
from the analysis, the electric-field threshold for cell death
became 496 V/cm and 500 V/cm for the 300 V and 450 V
groups, respectively.
Overlaying the 500 V/cm contour on the live/dead stained
images of the in vitro tumors from each of these groups
illustrates the accuracy of the numerical model for deter-
mining the electric-field threshold for cell death (Fig. 7).
Although no data are present in the literature on the
threshold in pancreatic tumors, our result is comparable to
that obtained in vivo for brain tissue (23) when a similar
pulsing protocol was implemented. Results citing a higher
threshold of 637 V/cm in vivo for liver tissue were likely
due to a 10-fold reduction in the number of pulses delivered
(21), and this effect could be elucidated in future
experiments.Determination of electric-field threshold for cell
death in suspension
It is difficult to determine a distinct electric-field threshold
for cell death from the viability analysis on cell suspensions.
In the past, conservative estimates have been made under
the assumption that the threshold in vivo corresponds to
the value of the electric field, resulting in <5% viability in
suspension (31). Under the same logic, our results suggest
that a conservative estimate of the electric-field threshold
for cell death in vivo would be ~1500 V/cm (see Fig. S1).
In addition, at 500 V/cm there was no corresponding
reduction of cell viability in suspension. Similar results
have been shown for the onset of reversible electroporation,Biophysical Journal 103(9) 2033–2042
2040 Arena et al.which was found to occur at a significantly lower electric-
field strength in vivo compared to the same cells in suspen-
sion (56).DISCUSSION
Cancer cells cultured in 3D collagen I hydrogels were
shown to respond to IRE pulse delivery comparable to
published in vivo results. This included a similar electric-
field threshold for cell death (Table 3) (23), sparing of the
underlying collagen network (8), and submillimeter resolu-
tion at the boundary between treated and untreated regions
(Fig. 3) (8,9). Recently, collagen I hydrogels have been
used to study reversible electroporation and electrogene
transfer (57). In that study, conducted by Haberl and Pavlin,
it was found that electrogene transfer had a dependency on
plasmid concentration and pulse duration similar to that
seen in vivo when performed in a 3D in vitro environment.
Further, transfection was more pronounced on the surface
of the collagen I hydrogels, due to diffusion limitations
through the collagen mesh, which is also a characteristic
seen in vivo (58). Outside the field of electroporation, 3D
cell culture models have been shown to elicit an in-vivo-
like response for other cancer therapies, including che-
motherapy (59), radiation therapy (60), and nanoparticle
delivery (61). This platform could also be used to optimize
therapies that utilize low-intensity alternating electric fields
to arrest cell proliferation by disrupting cells during cleav-
age (62), as opposed to directly inducing cell death through
membrane disruption, as shown here.
Compared to conventional in vitro IRE-treatment-plan-
ning models, such as cell suspensions and cell-culture
monolayers, the 3D in vitro tumor model generated more
accurate predictability of IRE outcomes. This is likely due
to the ability of the cells cultured in 3D to reproduce the
cell-cell/cell-matrix interactions seen in the original tissue
that are important for dictating an in-vivo-like morphology.
As a result of cell protrusions interacting with the collagen
matrix, the cell diameters in the hydrogel are larger than
they are in suspension (13.1 mm). This may contribute to
the decreased electric-field threshold for cell death, as
a larger diameter increases the calculated transmembrane
potential (63):
D4ðqÞ ¼ 3
2
E a cosðqÞ; (6)
where a is the radius of the cell and q is the polar angle
measured from the center of the cell with respect to the
direction of the electric field. The induced transmembrane
potential creates a supraphysiologic electric field in the
membrane that is thought to be responsible for permeabili-
zation. For a membrane thickness of 5 nm, an external elec-
tric field of 500 V/cm applied across a cell in suspension
(D4max ¼ 0.98 V) generates a voltage/distance ratio onBiophysical Journal 103(9) 2033–2042the order of ~2 MV/cm within the membrane. In cell mono-
layers, 2D spatial information and limited cell-cell/cell-
matrix interactions can be obtained, but the path taken by
electrical current is significantly altered when compared to
a 3D environment (a majority of current flows through the
culture media over the top of cells that are adhered to a
highly insulative surface), which may alter the transmem-
brane potential and electric-field threshold for cell death.
Furthermore, analysis of dead cells is complicated by the
fact that they can detach from the culture surface.
Current measurements were unable to detect any dynamic
change in bulk electrical conductivity due to electroporation
for in vitro tumors consisting of 5  106 cells/ml. Specifi-
cally, at an applied voltage of 300 V, there was no statistical
difference in the change in current between the first and last
pulse when comparing the 5  106-cells/ml group to the
no-cells control group. Therefore, any dynamic changes in
bulk-tissue electrical conductivity due to electroporation
that have been reported in vivo (64) could be neglected
from the numerical model of the in vitro tumor. This greatly
reduced the number of parameters contributing to an accu-
rate determination of the electric-field threshold for IRE.
When the cell concentration was increased to 50  106
cells/ml, there was a significant decrease in the measured
current during treatment at 300 V compared to the no-cells
control and 5  106-cells/ml groups (data not shown). This
is unlike what happens in vivo, and it may be the result of the
fact that the cytoplasm has a lower electrical conductivity
than the extracellular space (65). Upon electroporation,
the release of cytosol into the extracellular space may domi-
nate the bulk electrical properties at this specific cell
concentration. At higher cell concentrations in tissue, the
bulk electrical properties during electroporation are domi-
nated by the creation of membrane defects, which greatly
increase the conductivity and resulting current during treat-
ment. According to the EMT model, a cell concentration on
the order of 340  106 cells/ml would be required to cut the
baseline conductivity of the in vitro tumors in half, from 1.2
S/m to 0.6 S/m, which is more electrically relevant to tissue
and corresponds to a volume fraction of 0.4. Due to diffu-
sion limitations through the collagen hydrogel, obtaining
such high concentrations while maintaining cell viability
is a challenging task. This will be the subject of future
work directed toward replicating the dynamic conductivity
changes seen in vivo on a 3D in vitro platform.
A current limitation of the relatively high electrical
conductivity of the in vitro tumors compared to an in vivo
environment is the added heat generated during treatment.
As a result, select protocols that do not cause significant
thermal damage in vivo may be unsuitable for testing
in vitro due to collagen I denaturation. Similar concerns
are present when treating cells in suspension. For the range
of applicable pulse parameters tested here, thermal changes
had a minimal influence on the electric field distribution.
This may be attributed to the small size of the in vitro tumor
IRE on 3D In Vitro Tumors 2041domain relative to the electrode spacing, which causes the
entire tumor to experience both an elevated temperature
and conductivity. In the future, the hydrogel volume could
be increased to mimic a clinical scenario in which the elec-
trodes are inserted into a targeted tumor and the treatment
region varies in all directions. Here, the experimental setup
was designed to induce a region of cell death that was
symmetric in the z-direction (Fig. 3).CONCLUSION
Performing IRE on a 3D in vitro tumor platform produced
an electric field dependence on cell death characteristic of
an in vivo response. Thus, this model is suitable for gener-
ating a wide range of data that will be useful in refining
treatment-planning algorithms used in clinical IRE proce-
dures. Specifically, studies correlating varying pulse param-
eters to ablation volume in a variety of cancer cell lines will
help identify both protocol-specific and cell-specific param-
eters to enhance the reliability of predicted outcomes. In
addition, there is the possibility of growing patient-specific
in vitro tumors from biopsied tissue. Further development of
this platform will facilitate the acceptance of IRE as a viable
cancer therapy.SUPPORTING MATERIAL
One figure, supporting references, and a detailed description of IRE pulse
delivery and viability analysis for cell suspensions are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(12)01032-6.
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